Press releases, Reports & Disclosures for Gulf Pharmaceutical Industries
Disclosures: Gulf Pharmaceutical Industries Announcements Regarding Unclaimed Cash Dividends of Shareholders
ADX Disclosures: JULPHAR Resumption Notice
Disclosures: Gulf Pharmaceutical Industries Management Discussion and Analysis Report for the Period Ended September 30,2022
Disclosures: Gulf Pharmaceutical Industries Financial Results for the Period Ended September 30,2022
Disclosures: Gulf Pharmaceutical Industries Board Meeting Results held on 09/11/2022 at 10:30
ADX Disclosures: Temporary suspension of trading on the shares of Gulf Pharmaceutical Industries
Disclosures: Gulf Pharmaceutical Industries Announcement of Board Meeting to be held on 09/11/2022 at 10:30
Disclosures: JULPHAR Announcements Resignation of the Chief Operating Officer
Disclosures: Gulf Pharmaceutical Industries Announcements Regarding Unclaimed Cash Dividends of Shareholders
ADX Disclosures: JULPHAR Resumption Notice